Drug resistant breast cancer may have met its match in a drug called metformin.
Dr. Terra Arnason and her team at the University of Saskatchewan took on a five-year-long study research the effects of metformin on multiple drug resistant breast cancer.
The results were impressive, even to Arnason.
"If my mom got cancer, would I suggest to her she take metformin? I would, actually!" Arnason said.
Metformin is typically prescribed to treat Type 2 diabetes. Other studies have shown metformin is an effective treatment for cancer, but this study took it one step further.
The findings suggesting metformin can keep breast cancer cells from developing drug resistance, and can reverse drug resistance after it has appeared. The study was published in December in the open-access journal PLOS One.
Read more at http://www.cbc.ca